Diabetic Technology Allmp; Medication
488 articles
- The Impact of Jdrf on the Innovation Pipeline for Next-generation Insulin Devices
- The Potential of Jdrf-supported Wearable Biosensors in Continuous Monitoring
- How Jdrf Is Supporting Research into T1d and Covid-19 Interactions
- The Impact of Jdrf on Developing Non-invasive Insulin Delivery Methods
- Jdrf’s Efforts to Improve Insulin Pump Technology and User Experience
- The Role of Jdrf in Funding Research for T1d-related Cardiovascular Complications
- Jdrf’s Initiatives to Advance Telehealth and Remote Monitoring Technologies
- The Impact of Jdrf-funded Research on the Development of Artificial Pancreas Algorithms
- How Jdrf Is Supporting the Development of Wearable Insulin Delivery Systems
- The Impact of Jdrf’s Research Funding on Insulin Production and Delivery Innovations
- How Jdrf Is Accelerating the Development of Bioartificial Pancreas Devices
- Jdrf's Efforts to Improve Quality of Life for Children with T1d Through Innovative Technologies
- Understanding Jdrf's Efforts to Improve Glucose Monitoring Devices for T1d Patients
- Latest Breakthroughs in Islet Cell Transplantation Supported by Jdrf Initiatives
- The Impact of Jdrf Grants on the Future of Closed-loop Insulin Delivery Systems
- How Jdrf Funding Is Accelerating the Development of Artificial Pancreas Technology
- Latest Updates in Insulin Formulations for the Cde Exam
- The Role of Patient Education in Passing the Cde Exam
- The Importance of Patient Education in Recognizing Infection Symptoms Early
- The Role of Pharmacists in Identifying Dka Symptoms During Medication Reviews
- The Potential of Gene Editing in Creating Autoimmunity-resistant Pancreatic Cells
- Innovations in Delivery of Autoimmune Therapies Using Micro-needle Arrays
- The Potential of Cytokine Engineering in Autoimmune Response Suppression
- Progress in Developing Multi-functional Immune Modulation Devices for T1d
- The Use of Advanced Biomaterials to Create Immune-privileged Environments for Beta Cells
- Recent Advances in Tolerance-inducing Nanoparticles for Autoimmune Disease Prevention
- Innovative Approaches Using Light-activated Therapies to Modulate Autoimmune Responses
- Progress in Developing Artificial Intelligence-driven Autoimmune Disease Models
- The Potential of Lipid Nanoparticles in Autoimmune Therapy Delivery Systems
- Innovative Approaches to Deliver Autoimmune Therapies via Nanocarriers